Abstract
Gestational diabetes is becoming increasingly common; it is important to determine how it relates to future risk of disease. We investigated the relation of gestational diabetes to breast cancer in 37,926 women who had one or more live births in 1964–1976 for whom information had been collected on complications of pregnancy. In this cohort there were 1,626 cases of breast cancer reported to the Israel Cancer Registry before January 1, 2005 and 410 cases of gestational diabetes recorded from birth records. There were 29 cases of breast cancer among women diagnosed with gestational diabetes. Using Cox proportional hazards models to control for age and birth order at the first observed birth and other characteristics, we found that the incidence of breast cancer was increased among women diagnosed with gestational diabetes (relative rate = 1.5, 95% confidence interval 1.0–2.1). This effect was seen only among women 50 years and older (relative rate 1.7, 95% confidence interval 1.1–2.5) but not among women <50 (relative rate = 1.0, 95% confidence interval 0.5–2.1). The findings suggest that gestational diabetes may be an important early marker of breast cancer risk among post-menopausal women, but these results need to be confirmed in future studies.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115(3):485–491
Gestational diabetes mellitus. Diabetes Care (2003) 26 Suppl 1:S103–105
Green JR, Pawson IG, Schumacher LB, Perry J, Kretchmer N (1990) Glucose tolerance in pregnancy: ethnic variation and influence of body habitus. Am J Obstet Gynecol 163(1 Pt 1):86–92
Dooley SL, Metzger BE, Cho NH (1991) Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population. Diabetes 40(Suppl 2):25–29
Berkowitz GS, Lapinski RH, Wein R, Lee D (1992) Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 135(9):965–973
Murphy NJ, Bulkow LR, Schraer CD, Lanier AP (1991) Prevalence of diabetes mellitus in pregnancy among Yup’ik Eskimos and Alaska Coastal Indians, 1987–1988. Arctic Med Res, Suppl:423–426
Thorpe LE, Berger D, Ellis JA, Bettegowda VR, Brown G, Matte T, Bassett M, Frieden TR (2005) Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990–2001. Am J Public Health 95(9):1536–1539
Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28(3):579–584
Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111
Dawson SI 2004 Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100(1):149–155
Troisi R, Weiss HA, Hoover RN, Potischman N, Swanson CA, Brogan DR, Coates RJ, Gammon MD, Malone KE, Daling JR et al 1998 Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9(6):641–647
Harlap S, Davies AM, Deutsch L, Calderon-Margalit R, Manor O, Paltiel O, Tiram E, Yanetz R, Perrin MC, Terry MB et al (2007) The Jerusalem Perinatal Study cohort, 1964–2005: methods and a review of the main results. Paediatr Perinat Epidemiol (in press)
Harlap S, Davies AM, Grover NB, Prywes R (1977) The Jerusalem Perinatal Study: the first decade 1964–1973. Isr J Med Sci 13:1073–1091
Investigation into the completeness for the Israel Cancer Registry. Methods and results. Publication 230. (In Hebrew). In: Israel Center for Disease Control 2003
Hosmer DW, Lemeshow S (1999) Applied survival analysis. John Wiley & Sons, Inc., New York
Niedowicz DM, Daleke DL (2005) The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43:289–330
Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T (1996) Oxidative damage to DNA in diabetes mellitus. The Lancet 347:444–445
Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868
Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care 26(6):1752–1758
Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75(11):1699–1703
Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71(3):360–363
Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194–202
Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98:349–356
Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12(10):875–880
Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156(4):349–352
Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes-a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241(6):471–475
La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953
Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28(5):816–823
Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283(19):2552–2558
Le Roith D (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336(9):633–640
Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66(2):266–272
Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279–292
Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF (2002) A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44(2):127–138
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296(2):193–201
Acknowledgements
We thank the women, men and offspring who participated in the Jerusalem Perinatal Study. Funding: This study was funded by the National Institutes of Health (RO1CA80197)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perrin, M.C., Terry, M.B., Kleinhaus, K. et al. Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat 108, 129–135 (2008). https://doi.org/10.1007/s10549-007-9585-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-007-9585-9